Inventor · disambiguated record
Ryohei Katayama
Also filed as: KATAYAMA Ryohei
5 granted patents·6 pending applications·10 citations·filing 2017–2024
70Inventor score
Top patents by PatentIndex Score
11 records- 0189US10813933B2Therapeutic agent for lung cancer that has acquired EGFR-TKI resistanceJAPANESE FOUND FOR CANCER RES·Filed 2017·Granted Oct 27, 2020·8 cites·3 claims
- 0283US10921311B2Fusions and method for detecting sameJAPANESE FOUND FOR CANCER RES·Filed 2017·Granted Feb 16, 2021·2 cites·3 claims
- 0374US2023323475A1Test method, of dividing blastic plasmacytoid dendritic cell neoplasm (bpdcn) into subtypesJAPANESE FOUND FOR CANCER RES·Filed 2023·Application pending·0 cites
- 0473US2023407266A1Primary culture methodTOPPAN PRINTING CO LTD·Filed 2023·Application pending·0 cites
- 0569US12055538B2Fusions and method for detecting sameJAPANESE FOUND FOR CANCER RES·Filed 2021·Granted Aug 6, 2024·0 cites·2 claims
- 0669US2024426809A1Evaluation method of anticancer drug and selection method of anticancer drugTOPPAN HOLDINGS INC·Filed 2024·Application pending·0 cites
- 0765US11419871B2Therapeutic agent for lung cancer that has acquired EGFR-TKI resistanceJAPANESE FOUND FOR CANCER RES·Filed 2020·Granted Aug 23, 2022·0 cites·10 claims
- 0863US11781115B2Primary culture methodTOPPAN PRINTING CO LTD·Filed 2020·Granted Oct 10, 2023·0 cites·15 claims
- 0957US2024285587A1Novel therapeutic agent that suppresses metastasis and proliferation of osteosarcoma and gliomaJAPANESE FOUND FOR CANCER RES·Filed 2022·Application pending·0 cites
- 1055US2025099461A1Application of gilteritinib to various mutantsJAPANESE FOUND FOR CANCER RES·Filed 2022·Application pending·0 cites
- 1143US2019017125A1Diagnosis marker for rare hematopoietic tumor, test method, therapeutic agent, and screening methodJAPANESE FOUND FOR CANCER RES·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ryohei Katayama files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →